Segment Reporting (Tables)

9 Months Ended

Sep. 30, 2019

Segment Reporting [Abstract]

Schedule of Segment Information

The tables below present segment information reconciled to total Company loss from operations, with segment operating loss including gross profit less direct research and development expenses and direct selling, general and administrative expenses to the extent specifically identified by segment:

	Three Months Ended September 30, 2019
	Water Filtration			Renal Products			Nephros, Inc. Consolidated
Total net revenues	$	3,095,000		$	-		$	3,095,000
Gross margin		1,819,000			-			1,819,000
Research and development expenses		411,000			366,000			777,000
Depreciation and amortization expense		44,000			-			44,000
Selling, general and administrative expenses		1,756,000			31,000			1,787,000
Change in fair value of contingent consideration		(94,000	)		-			(94,000	)
Total operating expenses		2,117,000			397,000			2,514,000
Loss from operations	$	(298,000	)		(397,000	)		(695,000	)

	Nine Months Ended September 30, 2019
	Water Filtration			Renal Products			Nephros, Inc. Consolidated
Total net revenues	$	7,173,000			-		$	7,173,000
Gross margin		4,184,000			-			4,184,000
Research and development expenses		1,190,000			1,136,000			2,326,000
Depreciation and amortization expense		142,000			-			142,000
Selling, general and administrative expenses		4,577,000			116,000			4,693,000
Change in fair value of contingent consideration		(113,000	)		-			(113,000	)
Total operating expenses		5,796,000			1,252,000			7,048,000
Loss from operations	$	(1,612,000	)		(1,252,000	)		(2,864,000	)

	Three Months Ended September 30, 2018
	Water Filtration			Renal Products			Nephros, Inc. Consolidated
Total net revenues	$	1,724,000		$	-		$	1,724,000
Gross margin		952,000			-			952,000
Research and development expenses		147,000			205,000			352,000
Depreciation and amortization expense		42,000			-			42,000
Selling, general and administrative expenses		970,000			99,000			1,069,000
Total operating expenses		(1,159,000	)		(304,000	)		(1,463,000	)
Loss from operations	$	(207,000	)	$	(304,000	)	$	(511,000	)

	Nine Months Ended September 30, 2018
	Water Filtration			Renal Products			Nephros, Inc. Consolidated
Total net revenues	$	4,075,000		$	-		$	4,075,000
Gross margin		2,249,000			-			2,249,000
Research and development expenses		598,000			395,000			993,000
Depreciation and amortization expense		123,000			-			123,000
Selling, general and administrative expenses		3,298,000			122,000			3,420,000
Total operating expenses		(4,019,000	)		(517,000	)		(4,536,000	)
Loss from operations	$	(1,770,000	)	$	(517,000	)	$	(2,287,000	)